Zempreon CFC-FREE Inhaler

Zempreon is a salbutamol-based inhaler used for the relief of asthma symptoms. It is a brand associated with the pharmaceutical company Viatris, which was formed through the merger of Mylan and Upjohn, a division originally belonging to Pfizer. The product shown includes an 'AUST R' number, indicating it is registered for the Australian market.

Ownership of the Zempreon brand lies with Viatris Inc., a global healthcare company headquartered in the United States. While the corporate headquarters are in the US, manufacturing for such pharmaceutical products is typically distributed across several international facilities to ensure global supply, relying on a complex network of production sites in various regions.